Literature DB >> 21667591

The Minnesota Prescription Monitoring Program.

Cory Herman1.   

Abstract

We must keep in mind that health care professionals practice in an environment of legal and regulatory influences, where some patients with pain also have an addictive disease. As dentists routinely manage acute oral and dental pain by pharmacological means, people who abuse prescription medications see dentists as easy targets to "score" prescription opioids and controlled substances. This potential for deception must be balanced with our professional responsibility to prescribe and dispense controlled substances appropriately, guarding against abuse while ensuring that patients have medication available when appropriate and necessary. However, dentists also have a personal responsibility to protect themselves and their practices from becoming easy targets for drug abuse and diversion. Becoming aware of the potential signs and symptoms of drug seeking behavior and recognizing the signs of controlled substance misuse will safeguard patients, practices, and practitioners. Utilizing the services of the Minnesota Prescription Monitoring Program may help to not only improve patient care, but to facilitate appropriate pain management and help identify patients having drug seeking behaviors

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667591

Source DB:  PubMed          Journal:  Northwest Dent        ISSN: 0029-2915


  5 in total

1.  Dental opioid prescribing and multiple opioid prescriptions among dental patients: Administrative data from the South Carolina prescription drug monitoring program.

Authors:  Jenna L McCauley; J Madison Hyer; V Ramesh Ramakrishnan; Renata Leite; Cathy L Melvin; Roger B Fillingim; Christie Frick; Kathleen T Brady
Journal:  J Am Dent Assoc       Date:  2016-04-05       Impact factor: 3.634

2.  Training experiences regarding pain management, addiction, and drug diversion of dentists enrolled in the National Dental Practice-Based Research Network.

Authors:  Jenna L McCauley; Stephanie Reyes; Cyril Meyerowitz; Valeria V Gordan; D Brad Rindal; Gregg H Gilbert; Renata S Leite; Roger B Fillingim; Kathleen T Brady
Journal:  Subst Abus       Date:  2019-03-04       Impact factor: 3.716

3.  Opioid prescribing and risk mitigation implementation in the management of acute pain: Results from The National Dental Practice-Based Research Network.

Authors:  Jenna L McCauley; Renata S Leite; Valeria V Gordan; Roger B Fillingim; Gregg H Gilbert; Cyril Meyerowitz; David Cochran; D Brad Rindal; Kathleen T Brady
Journal:  J Am Dent Assoc       Date:  2018-03-15       Impact factor: 3.634

4.  Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.

Authors:  Jenna L McCauley; Renata S Leite; Cathy L Melvin; Roger B Fillingim; Kathleen T Brady
Journal:  Subst Abus       Date:  2015-12-16       Impact factor: 3.716

5.  Patterns of opioid prescribing by dentists in a pediatric population: a retrospective observational study.

Authors:  Debora C Matthews; Martha G S Brillant; Kudirat O Jimoh; Winston Singleton; Pamela McLean-Veysey; Ingrid Sketris
Journal:  CMAJ Open       Date:  2019-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.